Effectiveness of infliximab for intralymphatic histiocytosis with rheumatoid arthritis

Arch Dermatol. 2011 Jan;147(1):131-3. doi: 10.1001/archdermatol.2010.407.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Histiocytosis / drug therapy*
  • Histiocytosis / etiology
  • Histiocytosis / pathology
  • Humans
  • Infliximab
  • Lymphatic Diseases / drug therapy
  • Lymphatic Diseases / etiology
  • Lymphatic Diseases / pathology
  • Lymphatic Vessels / pathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab